Report

Global Joint Pain Injections Market Size study & Forecast, by Injection Type, by Joint Type, by Distribution Channel and Regional Analysis, 2022-2029

  • Publish Date: Feb,2023
  • Report ID: 3-2-1588
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Joint Pain Injections Market, by Region, 2019-2029 (USD Billion)
1.2.2. Joint Pain Injections Market, by Injection Type, 2019-2029 (USD Billion)
1.2.3. Joint Pain Injections Market, by Joint Type, 2019-2029 (USD Billion)
1.2.4. Joint Pain Injections Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Joint Pain Injections Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Joint Pain Injections Market Dynamics
3.1. Joint Pain Injections Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of osteoarthritis and rheumatoid arthritis
3.1.1.2. Growing need for affordable treatment solutions
3.1.1.3. Rising rate of injuries due to accidents
3.1.2. Market Challenges
3.1.2.1. Stringent regularity framework
3.1.3. Market Opportunities
3.1.3.1. Rising geriatric population
3.1.3.2. Growing healthcare infrastructure in developing regions
Chapter 4. Global Joint Pain Injections Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Joint Pain Injections Market, by Injection Type
6.1. Market Snapshot
6.2. Global Joint Pain Injections Market by Injection Type, Performance - Potential Analysis
6.3. Global Joint Pain Injections Market Estimates & Forecasts by Injection Type 2019-2029 (USD Billion)
6.4. Joint Pain Injections Market, Sub Segment Analysis
6.4.1. Interleukin Inhibitors
6.4.2. Hyaluronic Acid Injections
Chapter 7. Global Joint Pain Injections Market, by Joint Type
7.1. Market Snapshot
7.2. Global Joint Pain Injections Market by Joint Type, Performance - Potential Analysis
7.3. Global Joint Pain Injections Market Estimates & Forecasts by Joint Type 2019-2029 (USD Billion)
7.4. Joint Pain Injections Market, Sub Segment Analysis
7.4.1. Knee and Ankle
7.4.2. Hip Joint
7.4.3. Shoulder and Elbow
7.4.4. Facet Joints of the Spine
Chapter 8. Global Joint Pain Injections Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Joint Pain Injections Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Joint Pain Injections Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Joint Pain Injections Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Drug Stores and Retail Pharmacies
8.4.3. Online Providers
Chapter 9. Global Joint Pain Injections Market, Regional Analysis
9.1. Joint Pain Injections Market, Regional Market Snapshot
9.2. North America Joint Pain Injections Market
9.2.1. U.S. Joint Pain Injections Market
9.2.1.1. Injection Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Joint Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Joint Pain Injections Market
9.3. Europe Joint Pain Injections Market Snapshot
9.3.1. U.K. Joint Pain Injections Market
9.3.2. Germany Joint Pain Injections Market
9.3.3. France Joint Pain Injections Market
9.3.4. Spain Joint Pain Injections Market
9.3.5. Italy Joint Pain Injections Market
9.3.6. Rest of Europe Joint Pain Injections Market
9.4. Asia-Pacific Joint Pain Injections Market Snapshot
9.4.1. China Joint Pain Injections Market
9.4.2. India Joint Pain Injections Market
9.4.3. Japan Joint Pain Injections Market
9.4.4. Australia Joint Pain Injections Market
9.4.5. South Korea Joint Pain Injections Market
9.4.6. Rest of Asia Pacific Joint Pain Injections Market
9.5. Latin America Joint Pain Injections Market Snapshot
9.5.1. Brazil Joint Pain Injections Market
9.5.2. Mexico Joint Pain Injections Market
9.5.3. Rest of Latin America Joint Pain Injections Market
9.6. Rest of The World Joint Pain Injections Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. AbbVie Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Anika Therapeutics
10.2.3. Bioventus
10.2.4. Eli Lilly and Company
10.2.5. Ferring Pharmaceuticals Inc.
10.2.6. PACIRA BIOSCIENCES (Flexion Therapeutics, Inc.)
10.2.7. Pfizer Inc.
10.2.8. Sanofi S.A.
10.2.9. Teva Pharmaceuticals
10.2.10. Zimmer Biomet
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption